229 related articles for article (PubMed ID: 19766646)
1. Long-term probability of and mortality from de novo malignancy after liver transplantation.
Watt KD; Pedersen RA; Kremers WK; Heimbach JK; Sanchez W; Gores GJ
Gastroenterology; 2009 Dec; 137(6):2010-7. PubMed ID: 19766646
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors and Outcomes of De Novo Cancers (Excluding Nonmelanoma Skin Cancer) After Liver Transplantation for Primary Sclerosing Cholangitis.
Mouchli MA; Singh S; Loftus EV; Boardman L; Talwalkar J; Rosen CB; Heimbach JK; Wiesner RH; Hasan B; Poterucha JJ; Kymberly WD
Transplantation; 2017 Aug; 101(8):1859-1866. PubMed ID: 28272287
[TBL] [Abstract][Full Text] [Related]
3. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
[TBL] [Abstract][Full Text] [Related]
4. Gender, Race and Disease Etiology Predict De Novo Malignancy Risk After Liver Transplantation: Insights for Future Individualized Cancer Screening Guidance.
Bhat M; Mara K; Dierkhising R; Watt KD
Transplantation; 2019 Jan; 103(1):91-100. PubMed ID: 29377876
[TBL] [Abstract][Full Text] [Related]
5. The 28-year incidence of de novo malignancies after liver transplantation: A single-center analysis of risk factors and mortality in 1616 patients.
Rademacher S; Seehofer D; Eurich D; Schoening W; Neuhaus R; Oellinger R; Denecke T; Pascher A; Schott E; Sinn M; Neuhaus P; Pratschke J
Liver Transpl; 2017 Nov; 23(11):1404-1414. PubMed ID: 28590598
[TBL] [Abstract][Full Text] [Related]
6. The impact of inflammatory bowel disease post-liver transplantation for primary sclerosing cholangitis.
Joshi D; Bjarnason I; Belgaumkar A; O'Grady J; Suddle A; Heneghan MA; Aluvihare V; Rela M; Heaton N; Agarwal K
Liver Int; 2013 Jan; 33(1):53-61. PubMed ID: 22103794
[TBL] [Abstract][Full Text] [Related]
7. Differences in Phenotypes and Liver Transplantation Outcomes by Age Group in Patients with Primary Sclerosing Cholangitis.
Henson JB; Patel YA; Wilder JM; Zheng J; Chow SC; King LY; Muir AJ
Dig Dis Sci; 2017 Nov; 62(11):3200-3209. PubMed ID: 28391417
[TBL] [Abstract][Full Text] [Related]
8. Longterm Risk of Solid Organ De Novo Malignancies After Liver Transplantation: A French National Study on 11,226 Patients.
Sérée O; Altieri M; Guillaume E; De Mil R; Lobbedez T; Robinson P; Segol P; Salamé E; Abergel A; Boillot O; Conti F; Chazouillères O; Debette-Gratien M; Debray D; Hery G; Dharancy S; Durand F; Duvoux C; Francoz C; Gugenheim J; Hardwigsen J; Houssel-Debry P; Jacquemin E; Kamar N; Latournerie M; Lebray P; Leroy V; Mazzola A; Neau-Cransac M; Pageaux GP; Radenne S; Saliba F; Samuel D; Vanlemmens C; Woehl-Jaegle ML; Launoy G; Dumortier J
Liver Transpl; 2018 Oct; 24(10):1425-1436. PubMed ID: 30021061
[TBL] [Abstract][Full Text] [Related]
9. Coffee consumption protects against progression in liver cirrhosis and increases long-term survival after liver transplantation.
Friedrich K; Smit M; Wannhoff A; Rupp C; Scholl SG; Antoni C; Dollinger M; Neumann-Haefelin C; Stremmel W; Weiss KH; Schemmer P; Gotthardt DN
J Gastroenterol Hepatol; 2016 Aug; 31(8):1470-5. PubMed ID: 26880589
[TBL] [Abstract][Full Text] [Related]
10. Long-term Outcomes and Risk Factors After Adult Living Donor Liver Transplantation.
Imai D; Yoshizumi T; Sakata K; Ikegami T; Itoh S; Harada N; Motomura T; Toshima T; Mano Y; Soejima Y; Maehara Y
Transplantation; 2018 Sep; 102(9):e382-e391. PubMed ID: 29912047
[TBL] [Abstract][Full Text] [Related]
11. Spectrum of De Novo Cancers and Predictors in Liver Transplantation: Analysis of the Scientific Registry of Transplant Recipients Database.
Zhou J; Hu Z; Zhang Q; Li Z; Xiang J; Yan S; Wu J; Zhang M; Zheng S
PLoS One; 2016; 11(5):e0155179. PubMed ID: 27171501
[TBL] [Abstract][Full Text] [Related]
12. De novo malignancies following liver transplantation: a case-control study with long-term follow-up.
Yao FY; Gautam M; Palese C; Rebres R; Terrault N; Roberts JP; Peters MG
Clin Transplant; 2006; 20(5):617-23. PubMed ID: 16968488
[TBL] [Abstract][Full Text] [Related]
13. Secondary sclerosing cholangitis in critically ill patients has a poor outcome but lower tumour incidence than primary sclerosing cholangitis.
Kirstein MM; Book T; Manns MP; von Hahn T; Voigtländer T
United European Gastroenterol J; 2020 Jul; 8(6):716-724. PubMed ID: 32366182
[TBL] [Abstract][Full Text] [Related]
14. Clinical analysis of liver transplantation in autoimmune liver diseases.
Zhong CP; Xi ZF; Xia Q
Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):27-31. PubMed ID: 29428100
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive regimen and risk for de novo malignancies after liver transplantation for alcoholic liver disease.
Dumortier J; Maucort-Boulch D; Poinsot D; Thimonier E; Chambon-Augoyard C; Ducroux E; Vallin M; Walter T; Robinson P; Guillaud O; Boillot O
Clin Res Hepatol Gastroenterol; 2018 Oct; 42(5):427-435. PubMed ID: 29861393
[TBL] [Abstract][Full Text] [Related]
16. Patients with Alcoholic Liver Disease Have Worse Functional Status at Time of Liver Transplant Registration and Greater Waitlist and Post-transplant Mortality Which Is Compounded by Older Age.
McCabe P; Galoosian A; Wong RJ
Dig Dis Sci; 2020 May; 65(5):1501-1511. PubMed ID: 31642005
[TBL] [Abstract][Full Text] [Related]
17. Effects of Primary Sclerosing Cholangitis on Risks of Cancer and Death in People With Inflammatory Bowel Disease, Based on Sex, Race, and Age.
Trivedi PJ; Crothers H; Mytton J; Bosch S; Iqbal T; Ferguson J; Hirschfield GM
Gastroenterology; 2020 Sep; 159(3):915-928. PubMed ID: 32445859
[TBL] [Abstract][Full Text] [Related]
18. De Novo Malignancy After Heart, Kidney, and Liver Transplant: A Nationwide Study in Taiwan.
Yeh CC; Khan A; Muo CH; Yang HR; Li PC; Chang CH; Chen TL; Jeng LB; Liao CC
Exp Clin Transplant; 2020 Apr; 18(2):224-233. PubMed ID: 32133940
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of donation after circulatory death liver transplantation in primary sclerosing cholangitis.
Trivedi PJ; Scalera I; Slaney E; Laing RW; Gunson B; Hirschfield GM; Schlegel A; Ferguson J; Muiesan P
J Hepatol; 2017 Nov; 67(5):957-965. PubMed ID: 28690174
[TBL] [Abstract][Full Text] [Related]
20. De Novo Malignancies Screening After Liver Transplantation for Alcoholic Liver Disease: A Comparative Opportunistic Study.
Renaud L; Hilleret MN; Thimonier E; Guillaud O; Arbib F; Ferretti G; Jankowski A; Chambon-Augoyard C; Erard-Poinsot D; Decaens T; Boillot O; Leroy V; Dumortier J
Liver Transpl; 2018 Dec; 24(12):1690-1698. PubMed ID: 30207421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
